Ideas/Opinion: Biotech Stocks Trading Near Cash Value


20-Nov-2018 19:29 PM



    Since the start of October, the biotechnology sector plunges to uncharted territory. The iShares Nasdaq Biotechnology ETF (IBB) drops 19%, the Spdr S&P Biotech Etf (XBI) drops ~24% since October. This elevator down leaves investors in shocked, and most are staying away from the sector. But for a value investor, this may come as an opportunity to invest. One of the key metrics I look for when the sector took this huge drops is the company's cash per share.  Here are the small-cap biotech companies trading near or above their cash price.

  1. Aduro Biotech Inc (ADRO)
  2. Ardelyx Inc (ARDX)
  3. Calithera Biosciences Inc (CALA)
  4. Catalyst Biosciences Inc (CBIO)
  5. Corvus Pharmaceuticals Inc (CRVS)
  6. Jounce Therapeutics Inc (JNCE)
  7. Magenta Therapeutics Inc (MGTA)
  8. Melinta Therapeutics Inc (MLNT)
  9. Otonomy Inc (OTIC)
  10. Pieris Pharmacutitcals Inc (PIRS)
  11. Paratek Pharmaceuticals Inc (PRTK)
  12. Scpharmaceuticals Inc (SCPH)
  13. Surface Oncology Inc (SURF)
  14. Synlogic Inc (SYBX)
  15. Xenon Pharmaceuticals (XENE)
  16. Zosano Pharma Corp (ZSAN)
  17. Zynerba Pharmaceuticals Inc (ZYNE)

We know there are more biotech stocks out there trading near cash value, feel free to share your comment to the list.

Disclaimer: I (we) do not hold any long positions from the stocks mentioned above. These are ideas and opinion only.

Contact us:

Twitter: @BiotechMoney18




Add Your Comment

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.